These aren't just American companies - they're global powerhouses with operations worldwide. From Coca-Cola's international reach to Johnson & Johnson's healthcare dominance, you're investing in true market leaders.
These blue-chip giants have weathered decades of market cycles and economic storms. Their inclusion in the prestigious Dow Jones Industrial Average speaks to their proven resilience and consistent performance.
For Brazilian investors, these US stocks offer natural currency hedging and exposure to the world's largest economy. It's a smart way to diversify beyond domestic market volatility.
Market capitalisation breakdown for a US blue-chip basket aimed at Brazilian investors.
JNJ: $459.75B
PG: $345.20B
KO: $287.49B
For Brazilian investors seeking stability beyond domestic market volatility, US blue-chip companies offer exposure to global economic leaders. These Dow Jones Industrial Average constituents represent 30 of America's most influential and financially sound corporations, providing access to dollar-denominated assets and mature global economies.
This group focuses on established US market leaders known for their long histories, market dominance, and consistent performance. These blue-chip stocks span technology, industrials, healthcare, and consumer goods sectors, offering diversification across the American economy whilst potentially hedging against local currency fluctuations.
These specific companies were handpicked as constituents of the prestigious Dow Jones Industrial Average, representing world-renowned firms with proven track records. Professional analysts selected these names for their financial strength, global reach, and ability to anchor portfolios with established, reliable performance.
For Brazilians seeking portfolio stability away from domestic market volatility, US blue-chip companies offer exposure to global economic leaders. This basket contains shares of established, US-listed industrial and technology firms that form the Dow Jones Industrial Average.
10์ 14 ๊ฒ์
์ด ๋ฐ์ค์ผ์ ์ ์ฒด ์คํ ๋ฆฌ๋ฅผ ํ์ธํ์ธ์. ๋ฆฌ์คํฌ์ ์ ์ฌ๋ ฅ์ ๋ค๋ฃฌ ์์ธ ๊ธฐ์ฌ๋ฅผ ์ฝ์ด๋ณด์ธ์.
์ธ์ฌ์ดํธ ์ ์ฒด ์ฝ๊ธฐ
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Here are a few of the assets in this group. Create an account to unlock the full list.
Join Nemo FREE today and unlock every stock
60์ด๋ฉด ์ถฉ๋ถํฉ๋๋ค.
์ ๋๋ฆฌ์คํธ๋ค์ ์ด ๊ทธ๋ฃน์ ์์ฐ์ด ํฅํ 1๋ ๊ฐ ํ๊ท 1.25% ์ฑ์ฅํ ๊ฒ์ผ๋ก ์์ํฉ๋๋ค.
์ด ๊ทธ๋ฃน์ ์์ฐ 9๊ฐ ์ค 8๊ฐ๊ฐ ์ ๋ฌธ ์ ๋๋ฆฌ์คํธ๋ก๋ถํฐ ๋งค์ ์๊ฒฌ์ ๋ฐ์์ต๋๋ค.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
์ด ์์ฐ๋ค์ ํฌ์ํ๋ค๋ฉด:
12๊ฐ์ ํ ์์ ๊ฐ์น:
+1.25%
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
